|
|
 |
Accura
The brief was to build a communications programme to assist Accura with their IPO and listing on the PLUS market, and create a viable business model. |
 |
BioFocus
The company wished to increase it’s visibility in the crowded
marketplace and stand-out from the competition. A new corporate identity
was created that successfully re-focused their positioning. |
 |
DxS
The launch by the FDA of a new set of guidelines on Pharmacogenomics
(PGx) Data Submission, provided DxS with an ideal opportunity to derive
the maximum amount of pre and post-launch publicity. |
 |
Roche
Pharma Partnering
Roche PP wanted to build a reputation as a distinctive partner within
the biotechnology sector to enable it to offer strong, valuable relationships
to partners and to attract the best new opportunities. |
 |
Antisoma
Following its groundbreaking oncology deal with Roche, Antisoma decided
to take the opportunity to broaden its European investor base with
a targeted PR programme. |
|
